10.1210/jc.2014-2134 [DOI] [PMC free article] [PubMed] [Google Scholar] Yoshino O., Hayashi T., Osuga Y., Orisaka M., Asada H., Okuda S., et al
Why Choose: Popular for its potent formula and visible results
it has implications for: Trial design Patient selection Outcome measurement Ultimately, obesity is not defined by how much fat a patient has, but by where that fat is affecting physiology
Bottom Line: Which should I use Tirzepatide or Semaglutide
Semaglutide is a glucagon-like peptide (GLP-1) receptor agonist that supports healthy blood sugar levels
Ipamorelin is not FDA-approved as a prescription drug in the U.S., so product quality and labeling accuracy can be a major concern outside legitimate medical oversight